Co-Q10 300 mg

Co-Q10 300 mg

Carlson4.5 (63 ratings)
Format:Softgel Quantity: 30 Softgel(s) · 30 servings
Goals
$33.15 $1.10 per serving

Product analysis

49 out of 100

Co-Q10 300 mg supports normal cellular energy production, with limited relevance to selected heart-related measures. Its relatively high cost and unspecified preparation make value harder to judge.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality26

The CoQ10 preparation is unspecified, limiting a firm form comparison. Vitamin E is named, but the information does not establish the quality of the whole combination.

Ingredient Transparency72

The listed amounts are disclosed, making the serving quantities clear. Most preparation details are missing, including which CoQ10 form is used.

Value For Money27

The serving is relatively costly for its CoQ10 contribution. The separate value of vitamin E remains uncertain, so the combination does not offer a clear value advantage.

Customer Satisfaction67

Customer ratings are favorable. The small review base limits how widely that satisfaction picture can be applied.

Product Focus74

CoQ10 provides a clear focus on cellular energy and selected heart-related measures. Broader claims about fatigue, calorie burning or visible aging remain limited by preparation and health context.

Format
Softgel
Container
30 Softgel(s)
Per serving
$1.10
Customer rating
4.5 · 63 ratings
Report analysis

Goals

Energy
Impact
Moderate effect
B Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 300 mg

CoQ10 relates to mitochondrial energy production, with limited fatigue evidence tied to specific preparations. The 300 mg serving reaches the saved amount comparison, but the unidentified redox form limits transfer from those findings. A higher amount does not ensure a stronger fatigue benefit.

How this product is rated for Energy

Ingredient fit79

1 ingredients relate to energy, alongside 1 other actives that broaden the formula beyond this goal. The assessed amounts meet or closely approach the full comparison amounts.
Goal fit
1 ingredients relate to energy, alongside 1 other actives that broaden the formula beyond this goal.
Dose adequacy
The assessed amounts meet or closely approach the full comparison amounts.

Pathways17

The clearest connection is mitochondrial energy production, with limited support in the saved findings.
Depth
The clearest connection is mitochondrial energy production, with limited support in the saved findings.
Breadth
The assessed contributions remain too limited to show meaningful breadth across the goal pathways.

Evidence27

Coenzyme Q-10 provides the strongest evidence contribution in the saved assessment, with practical benefits dependent on the relevant nutritional or trial context. Direct transfer of trial findings is limited by preparation matching for Coenzyme Q-10.
Evidence strength
Coenzyme Q-10 provides the strongest evidence contribution in the saved assessment, with practical benefits dependent on the relevant nutritional or trial context.
Studied preparation
Direct transfer of trial findings is limited by preparation matching for Coenzyme Q-10.

Formulation logic100

The relevant ingredients can contribute alone or have the partners required by the saved findings. No conflict was identified in the supplied checks. 1 of 1 relevant ingredients meet the saved minimum amount criterion.
Partner coverage
The relevant ingredients can contribute alone or have the partners required by the saved findings.
Conflicts
No conflict was identified in the supplied checks.
Effective doses
1 of 1 relevant ingredients meet the saved minimum amount criterion.
Study evidence
Cardiovascular Support
Impact
Highest effect
A Ingredient FitC PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 300 mgVitamin E · 2 mg

Coenzyme Q10 has limited support for blood-pressure, lipid or blood-vessel lining markers in people with dyslipidemia or endothelial dysfunction. The declared amount meets the saved preparation amount benchmark. These findings do not establish cardiovascular-event prevention, relief of statin symptoms or superiority of a particular delivery form.

How this product is rated for Cardiovascular Support

Ingredient fit93

Coenzyme Q10 provide the goal connection. Coenzyme Q10 meets the saved preparation amount benchmark; more does not imply greater benefit.
Goal fit
Coenzyme Q10 give the product a focused connection to this goal.
Dose adequacy
Coenzyme Q10 meets the saved preparation amount benchmark; more does not imply greater benefit.

Pathways60

The strongest finding concerns blood-vessel lining function. Only one pathway reaches the saved coverage benchmark, so support remains focused.
Depth
The strongest finding concerns blood-vessel lining function.
Breadth
Only one pathway reaches the saved coverage benchmark, so support remains focused.

Evidence88

Coenzyme Q10 supplies the evidence finding, with limited marker results in selected populations.
Evidence strength
Coenzyme Q10 supplies the evidence finding, with limited marker results in selected populations.
Studied preparation
The saved finding accepts the counted preparations at qualifying amounts; this does not establish that the complete product was studied.

Formulation logic100

No missing required partner or configured conflict was found. All ingredients counted for this finding meet its saved amount threshold; this is not proof of clinical effectiveness.
Partner coverage
The counted ingredients do not lack a required partner under the saved finding; no added combination benefit is established.
Conflicts
No configured ingredient conflict was triggered in the supplied facts.
Effective doses
All ingredients counted for this finding meet its saved amount threshold; this is not proof of clinical effectiveness.
Study evidence
Vitamin E Mixed 79 studies
Longevity
Impact
Moderate effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 300 mg

Coenzyme Q10 supports normal cellular energy production and antioxidant processes. The serving supplies 300 mg, but the supplied skin-aging evidence concerns a particular water-soluble preparation, making the connection to visible aging limited and preparation-specific. Longer lifespan is not a supported outcome.

How this product is rated for Longevity

Ingredient fit93

CoQ10 gives the formula a focused connection to cellular function.
Goal fit
CoQ10 is the main relevant active, with no unrelated actives reducing focus.
Dose adequacy
The serving reaches the saved upper amount comparison; higher amounts do not imply greater benefit.

Pathways40

Support is concentrated in cellular energy production, with a smaller antioxidant contribution.
Depth
Mitochondrial energy production is the strongest area.
Breadth
Only cellular energy production has substantial coverage.

Evidence30

The evidence contribution is modest and preparation-specific.
Evidence strength
CoQ10 provides the strongest saved evidence contribution.
Studied preparation
The declared CoQ10 is not matched to the studied preparation.

Formulation logic100

The relevant ingredients meet most amount comparisons without a flagged conflict.
Partner coverage
No required partner is missing.
Conflicts
No configured ingredient conflict was found.
Effective doses
The relevant ingredient meets the saved minimum amount comparison.
Study evidence
Vitamin E Supportive 19 studies
Heart Health
Impact
High effect
B- Ingredient FitC- PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 300 mg

CoQ10 has limited support for blood-vessel function and selected blood-pressure measures. The declared active CoQ10 amount can be compared with ordinary oral CoQ10 evidence, but it does not identify an oxidation state or prove special delivery benefits. These findings do not establish general prevention of cardiovascular events.

How this product is rated for Heart Health

Ingredient fit74

Coenzyme Q-10 provide the included contribution, with partial coverage of the comparison amounts.
Goal fit
Coenzyme Q-10 contribute alongside ingredients directed at other uses.
Dose adequacy
The included amounts partly cover the saved comparison ranges, which compare exposure rather than establish treatment doses.

Pathways55

The strongest recorded connection is endothelial nitric-oxide function, with partial comparison-range coverage.
Depth
The strongest recorded connection is endothelial nitric-oxide function, with partial comparison-range coverage.
Breadth
One configured pathway reached the coverage threshold, so the contribution remains focused.

Evidence98

Coenzyme Q-10 provides the strongest included evidence; its clinical meaning remains limited by the outcomes and populations studied.
Evidence strength
Coenzyme Q-10 provides the strongest included evidence; its clinical meaning remains limited by the outcomes and populations studied.
Studied preparation
The included preparations were matched to studied material, without establishing benefit outside the studied outcomes or populations.

Formulation logic100

The included ingredients have no recorded partner gap or configured conflict and clear the minimum amount threshold.
Partner coverage
The included ingredients can stand alone or have their required partner present.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All included ingredients clear the saved minimum amount threshold; this does not guarantee a clinical benefit.
Study evidence
Metabolism Support
Impact
High effect
B Ingredient FitD+ PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 300 mg

Coenzyme Q-10 participates in the mitochondrial process that produces usable cellular energy. That normal role does not establish that supplementation increases whole-body energy expenditure. The supplied studies concern metabolic markers rather than a general increase in calorie burning, so the amount-based recognition in this comparison should not be interpreted as a lasting metabolic or weight-loss effect.

How this product is rated for Metabolism Support

Ingredient fit79

Coenzyme Q-10 leads the included ingredient findings. The retained amounts reach the upper comparison references.
Goal fit
The relevant ingredients share the formula with ingredients aimed at other health goals, reducing its concentration on this outcome.
Dose adequacy
The included amounts reach their upper comparison references; these are not proven doses for increasing calorie expenditure.

Pathways54

The connection is concentrated in mitochondrial energy and fat oxidation, with limited breadth across other routes. This is distinct from demonstrated whole-body thermogenesis.
Depth
Mitochondrial energy and fat oxidation provide the strongest connection, but cellular processes are distinct from increased whole-body calorie expenditure.
Breadth
One route reaches meaningful coverage, leaving the connection concentrated rather than broad across thermogenic processes.

Evidence75

CoQ10’s mitochondrial role and metabolic-marker findings do not demonstrate a routine increase in whole-body energy expenditure.
Evidence strength
Coenzyme Q-10 leads the included evidence finding; its normal role or specific study outcomes do not establish a general metabolism boost.
Studied preparation
The retained ingredients meet the saved preparation comparison; this does not establish that the product increases whole-body energy expenditure.

Formulation logic100

The retained ingredients meet the partner and minimum amount conditions, with no listed conflict triggered. These findings do not establish a lasting metabolic-rate or weight-loss effect.
Partner coverage
The retained ingredients have no unmet partner requirement; this does not establish extra calorie expenditure from combining them.
Conflicts
None of the listed ingredient-conflict conditions was triggered by the supplied facts.
Effective doses
All retained ingredients meet the minimum amount condition, which is not a proven dose for raising whole-body energy expenditure.
Study evidence
Inflammation
Impact
Highest effect
A Ingredient FitC- PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 300 mgVitamin E · 2 mg

Coenzyme Q-10 has a limited connection to inflammatory markers and oxidative stress. Its supporting trial used ubiquinone in people with coronary artery disease taking statins, with a change in TNF-alpha but no clear endpoint change in CRP or IL-6. This serving supplies 300 mg, matching the amount used daily in that trial.

How this product is rated for Inflammation

Ingredient fit93

Coenzyme Q-10 is the relevant ingredient; the serving's relationship to the studied amount determines its saved amount finding.
Goal fit
Coenzyme Q-10 is the formula's relevant ingredient, giving it a focused connection to this goal.
Dose adequacy
The serving matches the amount used daily in the supplied ubiquinone trial.

Pathways59

The saved findings are concentrated in one pathway, giving a limited range of connections to this broad goal.
Depth
The strongest saved connection is oxidative and mitochondrial stress.
Breadth
Only one pathway reaches the saved coverage threshold, so the connection is narrow.

Evidence93

Ubiquinone has limited biomarker evidence in statin-treated coronary artery disease. The preparation match does not establish routine clinical efficacy.
Evidence strength
Coenzyme Q-10 provides the strongest saved evidence finding among the counted ingredients, while its specific human-evidence limitations still apply.
Studied preparation
The counted preparations match the saved preparation criteria; this does not remove the limitations of the underlying human findings.

Formulation logic100

The counted ingredients meet the saved minimum amounts and most partner requirements, with no matched conflict recorded.
Partner coverage
The counted ingredients can contribute alone or meet the saved partner requirements.
Conflicts
No matched conflict was recorded in the supplied calculation.
Effective doses
All counted ingredients reach the saved minimum amount threshold; this threshold is not proof of an effective clinical dose.
Study evidence
Vitamin E Supportive 20 studies

Ingredients

IngredientAmount per servingScore
Calories
10 Calorie(s)
Total Fat
1 Gram(s)
Vitamin E (D-Alpha-Tocopherol)
2 mg
Co-Q10
300 mg 26
Gluten Free Adults 18–50
Report overview
Coenzyme Q-10 · 300 mg OverallScore26
F Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value
Each serving records 300 mg of CoQ10. The evaluation flags an additive of concern, though the saved facts do not identify it.
How this ingredient is rated

Active Ingredient Quality & Bioavailability12

The saved facts do not identify whether the CoQ10 is ubiquinol or ubiquinone. The saved facts do not confirm a targeted absorption-enhancing delivery system or enhancer.
Molecular Form: Ubiquinol vs. Ubiquinone
The saved facts do not identify whether the CoQ10 is ubiquinol or ubiquinone.
Formulation & Absorption Enhancers
The saved facts do not confirm a targeted absorption-enhancing delivery system or enhancer.

Dose, Safety & Label Transparency42

300 mg of CoQ10 is recorded per serving. The evaluation flags an additive of concern without identifying it.
Clinical Dosage Alignment
300 mg of CoQ10 is recorded per serving.
Label Transparency & Fillers
The evaluation flags an additive of concern, but the saved facts do not identify it.

Value20

A whole-product serving costs about $1.10.
Price Per Effective Serving
A whole-product serving costs about $1.10.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
    Loffredo L; Perri L; Di Castelnuovo A; Iacoviello L; De Gaetano G; Violi F · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2016
    Meta-analysis16 studies pooledCardiovascular Support forVitamin E
  7. Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
    Chen B; Li Y; Li Z; Hu X; Zhen H; Chen H; Nie C; Hou Y; Zhu S; Xiao L; Li T · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2025
    Randomized trial90 participantsCardiovascular Support forVitamin E
  8. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
    Lonn E; Bosch J; Yusuf S; Sheridan P; Pogue J; Arnold JM; Ross C; Arnold A; Sleight P; Probstfield J; Dagenais GR; HOPE and HOPE-TOO Trial Investigators · JAMA · 2005
    Randomized trial9,541 participantsCardiovascular Support forVitamin E
  9. Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
    Liu Z; He Z; Xing Y · Journal of nutritional science · 2026
    Cohort study34,955 participantsCardiovascular Support forVitamin E
  10. Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
    Chin SF; Ibahim J; Makpol S; Abdul Hamid NA; Abdul Latiff A; Zakaria Z; Mazlan M; Mohd Yusof YA; Abdul Karim A; Wan Ngah WZ · Nutrition & metabolism · 2011
    Randomized trial62 participantsCardiovascular Support forVitamin E
  11. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  12. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  13. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  14. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  15. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  16. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  17. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  18. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  19. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  20. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10